Portfolio | Bio-Star Private Equity Fund, LLC

AorTx, Inc. AorTx, Inc. (previously CardiacMD) is developing device solutions that rapidly convert aortic valve replacement from being one of the most severely invasive heart surgical procedures to that of a minimally invasive, percutaneous, approach. AorTx, guided by seasoned medical device engineers and clinicians, is developing devices that cover the entire procedural solution for percutaneous heart valve therapy--from the implant itself to delivery and deployment of the valve.
Atritech www.atritech.net Atritech has developed the WATCHMAN®, an implantable device designed to capture clots that may form in the left atrial appendage of patients with atrial fibrillation, thereby reducing the risk of stroke and eliminating the need for long-term use of blood thinning medications.
Avantis Medical Systems, Inc. www.avantismedical.com Avantis Medical Systems, Inc. is a California-based medical device company founded to develop and manufacture catheter-based endoscopic devices. Its initial focus is on devices for use in both detecting and treating cancers of the gastrointestinal (GI) tract.
Devax, Inc. www.devax.net Devax is a medical device company based in Irvine, CA engaged in the development of a proprietary drug eluting stent system that provides a clinical solution to treat coronary, carotid and peripheral vascular bifurcation lesions.
Guided Delivery Systems Guided Delivery Systems (GDS) is a leader in developing percutaneous trans-catheter mitral annuloplasty systems for the treatment of mitral regurgitation associated with Congestive Heart Failure.
MiCardia, Inc. www.micardia.com MiCardia, Inc. is a developmental stage company combining metallurgical and polymeric sciences expertise with biomedical engineering to develop minimally-invasive devices for interventional cardiology and cardiac surgery. MiCardia has combined extensive technical engineering background with in-depth experience in the creation and design of novel device solutions for new therapies focused on the treatment of Congestive Heart Failure ("CHF").
Onset Medical www.onsetmedical.com Onset Medical Corporation engages in the development, manufacturing and marketing of percutaneous and minimally-invasive access devices to extend the diagnostic and therapeutic “reach” of surgeons and interventionalists with patented technology that provides guided and controlled deployment of sheath catheters.
ReVascular Therapeutics, Inc ReVascular Therapeutics, Inc. has pioneered advances in technology for the intravascular treatment of complex lesions and total occlusions that typically cannot be treated using current catheter-based technologies and products.
Setagon Setagon, Inc. is a medical device company that has created a “Programmed Elution System” (PES) for targeted delivery of drugs and other biologic substances on stents and other medical devices.
Triage Medical www.triagemed.com Triage Medical, Inc. is an emerging medical device company developing a new generation of orthopedic trauma devices for use by orthopedic and reconstructive surgeons.